The France-connected healthcare market is projected to grow from $1.83 Bn in 2022 to $12.67 Bn by 2030, registering a CAGR of 27.4% during the forecast period of 2022 - 2030. The main factors driving the growth would be government support, health tech startups and the rising geriatric population. The market is segmented by type, function and by application. Some of the major players include Sanofi, Withings, Voluntis, Evolucare, Apple, Microsoft, Siemens Healthineers and Medtronic.
The France-connected healthcare market is projected to grow from $1.83 Bn in 2022 to $12.67 Bn by 2030, registering a CAGR of 27.4% during the forecast period of 2022 - 2030. French healthcare spending in 2020 was $227 Bn, or around $3,364 per person. In terms of health spending as a proportion of GDP and per person in the past, France has outperformed the EU average. Prior to 2020, the economy's growth rate and the rate of increase in health spending were roughly equal. But, in response to the COVID-19 epidemic, which resulted in an 8% decline in GDP, it expanded more quickly.
In recent years, the connected healthcare market in France has expanded quickly as more patients and healthcare professionals use digital health technology to enhance healthcare access and delivery. The use of digital technologies to link patients, healthcare practitioners, and other system stakeholders is referred to as "connected healthcare." The emergence of connected healthcare technology has accelerated the evolution of the French healthcare industry over the past several years. To increase access to healthcare services and save costs, the government has been supporting the use of telemedicine, e-prescriptions, and other digital health technologies.
Market Growth Drivers
The France-connected healthcare market is expected to be driven by factors such as:
The following factors are expected to limit the growth of the connected healthcare market in France:
March 2022: Sanofi, a French pharmaceutical company, and DarioHealth, a digital health company, have agreed to a five-year, $30 Mn deal. As part of the agreement, Dario would have access to Sanofi's sales teams to promote the company's current products and incorporate Sanofi's products onto its platform.
February 2022: Withings has bought the health and fitness app 8fit in order to broaden its portfolio of tech-enabled consumer health products.
The French National Agency for Pharmaceuticals and Health Products Safety (ANSM), the National Authority for Health (HAS), and the French Data Protection Authority (CNIL) are some of the organisations that oversee the regulatory environment for connected healthcare in France (CNIL). These organisations guarantee the security and privacy of connected healthcare solutions.
The French government passed legislation in 2018 to encourage the use of telemedicine, which allows healthcare providers to deliver remote medical consultations and prescriptions. The government has also put in place a national health data infrastructure that makes it possible to gather and share health data for research.
The French healthcare system has a thorough reimbursement strategy that includes telemedicine and connected healthcare technologies as well as a wide spectrum of healthcare services. The government passed legislation in 2018 allowing the national health insurance system to reimburse doctors for teleconsultations. In other words, patients can access medical consultations remotely and get reimbursed for the consultation's expense.
The French National Authority for Health (HAS) oversees France's reimbursement regulations for connected healthcare systems. The HAS is in charge of assessing the therapeutic advantages and financial effects of medical technology and digital health solutions. The organisation evaluates these solutions' efficacy and safety to decide whether they qualify for payment.
1. Report Description of the France Connected Healthcare Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. France Connected Healthcare Market Executive Summary
2.1 France Connected Healthcare Market – Industry Snapshot & key buying criteria, 2021-2030
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of France Connected Healthcare Market
3.1 Market Growth Drivers Analysis
3.2 Market Restrains Analysis
4. France Connected Healthcare Market Segmentation
4.1 By Type
4.1.1 mHealth services
4.1.2 mHealth Devices
4.1.3 E- Prescription
4.2 By Function Type
4.2.1 Remote patient monitoring
4.2.2 Clinical monitoring
4.2.4 Others (Assisted Living)
4.3 By Application Type
4.3.1 Diagnosis and Treatment
4.3.2 Monitoring Application
4.3.3 Wellness and Prevention
4.3.4 Healthcare management
4.4 By End-user
4.4.1 Hospitals and Clinics
4.4.2 Home monitoring
5. France Connected Healthcare Market Share
5.1 Market Analysis, Insights, and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
7. Key Company Profiles
7.1 Company 1
7.1.2 Financial Performance
7.1.3 Product & Services
7.1.4 Strategic initiatives
7.2 Company 2
7.2.2 Financial Performance
7.2.3 Product & Services
7.2.4 Strategic initiatives
7.3 Company 3
7.3.2 Financial Performance
7.3.3 Product & Services
7.3.4 Strategic initiatives
7.4 Company 4
7.4.2 Financial Performance
7.4.3 Product & Services
7.4.4 Strategic initiatives
7.5 Company 5
7.5.2 Financial Performance
7.5.3 Product & Services
7.5.4 Strategic initiatives
8. Healthcare Policies and Regulatory Landscape
8.1 Healthcare Policies in France
8.2 Regulatory Framework in France
8.3 Pricing & Reimbursement Scenario in France Connected Healthcare Market
9. Factors Driving Future Growth
9.1 New Trends and Development France Connected Healthcare Market
9.2 Future Opportunities
10. Strategic Recommendations
By Type (Revenue, USD Billion):
Based on the Type the market is segmented into mHealth services, mHealth Devices, and E- Prescription
By FunctionType (Revenue, USD Billion):
By Application Type (Revenue, USD Billion):
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
The France-connected healthcare market is projected to grow from $1.83 Bn in 2022 to $12.67 Bn by 2030, registering a CAGR of 27.4% during the forecast period of 2022 - 2030.
The France-connected healthcare market is segmented by type (m-health services, m-health devices and e-prescription), by function (remote patient monitoring, clinical monitoring, telemedicine and others), and by application type (diagnosis and treatment, monitoring application, wellness and prevention, healthcare management and others).
Some of the major players in France's connected healthcare market are Sanofi, Withings, Voluntis, Evolucare, Apple, Microsoft, Siemens Healthineers and Medtronic.
This report addresses